IDO1 and early-onset autosomal dominant Alzheimer disease: IDO-1 inhibition also has therapeutic potential in the treatment of Alzheimer’s disease by mitigating the impact of amyloid-driven chronic CNS inflammation and the resultant generation of neurotoxic KP metabolites through the upregulated expression of IDO-1.